Celltrion Healthcare Ranks High in Search... Stock Price Up 3.15%
As of 10:33 AM on the 28th, Celltrion Healthcare is trading at 173,300 KRW, up 3.15% from the previous day. This marks a 47.87% increase compared to November 27. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners are tentatively recorded as net buyers of 6,000 shares. Over the past five days, individual investors have net sold 493,644 shares, while foreigners and institutions have net bought 455,816 shares and 65,175 shares, respectively.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump: "If I Had Imposed Tariffs to Protect Intel, TSMC Would Have Become Intel's"
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
